From: Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
Organ | Control | Vehicle Treated | WFA (2 mg/kg) | WFA (6 mg/kg) |
---|---|---|---|---|
BW (Initial) (g) | 18.71 ± 0.91 | 18.96 ± 2.11 | 19.14 ± 1.50 | 19.60 ± 0.76 |
BW (final) (g) | 20.83 ± 1.53 | 22.65 ± 2.00 | 22.68 ± 2.53 | 23.57 ± 1.23 |
Kidney (mg/g) | 6.26 ± 0.57 | 6.08 ± 1.03 | 4.95 ± 0.79 | 5.45 ± 0.49 |
Liver (mg/g) | 53.67 ± 4.65 | 44.54 ± 3.64 | 47.16 ± 15.88 | 41.18 ± 3.60 |
Spleen (mg/g) | 1.41 ± 0.53 | 2.06 ± 0.11 | 2.20 ± 1.74 | 2.78 ± 1.45 |
Heart (mg/g) | 5.56 ± 1.12 | 4.20 ± 0.21 | 4.97 ± 1.96 | 3.74 ± 0.23 |